CELC
Price
$85.12
Change
-$1.26 (-1.46%)
Updated
Aug 3, 10:42 AM (EDT)
Capitalization
4.21B
3 days until earnings call
Intraday BUY SELL Signals
GLSI
Price
$13.50
Change
-$0.52 (-3.71%)
Updated
Jul 31 closing price
Capitalization
198.16M
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs GLSI

CELC vs GLSI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CELC vs. GLSI commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (CELC: $86.38 vs. GLSI: $13.50)
Brand notoriety: CELC and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 24% vs. GLSI: 40%
Market capitalization -- CELC: $4.21B vs. GLSI: $198.16M
CELC [@Biotechnology] is valued at $4.21B. GLSI’s [@Biotechnology] market capitalization is $198.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish while GLSI’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 3 bullish, 7 bearish.
  • GLSI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GLSI is a better buy in the short-term than CELC.

Price Growth

CELC (@Biotechnology) experienced а +4.55% price change this week, while GLSI (@Biotechnology) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.83%. For the same industry, the average monthly price growth was -8.71%, and the average quarterly price growth was +2980.63%.

Reported Earning Dates

CELC is expected to report earnings on Aug 06, 2026.

GLSI is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($4.21B) has a higher market cap than GLSI($198M). CELC YTD gains are higher at: -13.395 vs. GLSI (-35.745). GLSI has higher annual earnings (EBITDA): -22.4M vs. CELC (-172.66M). CELC has more cash in the bank: 387M vs. GLSI (10.5M). CELC (0) and GLSI (0) have equivalent revenues.
CELCGLSICELC / GLSI
Capitalization4.21B198M2,127%
EBITDA-172.66M-22.4M771%
Gain YTD-13.395-35.74537%
P/E RatioN/AN/A-
Revenue00-
Total Cash387M10.5M3,686%
Total Debt323MN/A-
FUNDAMENTALS RATINGS
CELC vs GLSI: Fundamental Ratings
CELC
GLSI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
48100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5965
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLSI's Valuation (77) in the null industry is in the same range as CELC (84) in the Miscellaneous Commercial Services industry. This means that GLSI’s stock grew similarly to CELC’s over the last 12 months.

CELC's Profit vs Risk Rating (48) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for GLSI (100) in the null industry. This means that CELC’s stock grew somewhat faster than GLSI’s over the last 12 months.

CELC's SMR Rating (100) in the Miscellaneous Commercial Services industry is in the same range as GLSI (100) in the null industry. This means that CELC’s stock grew similarly to GLSI’s over the last 12 months.

CELC's Price Growth Rating (59) in the Miscellaneous Commercial Services industry is in the same range as GLSI (65) in the null industry. This means that CELC’s stock grew similarly to GLSI’s over the last 12 months.

CELC's P/E Growth Rating (100) in the Miscellaneous Commercial Services industry is in the same range as GLSI (100) in the null industry. This means that CELC’s stock grew similarly to GLSI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCGLSI
RSI
ODDS (%)
Bearish Trend 4 days ago
69%
Bullish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 7 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
GLSI
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BBUS134.600.97
+0.73%
JPMorgan BetaBuilders US Equity ETF
ROAM33.740.12
+0.35%
Hartford Multifactor Emerging Mkts ETF
CPSR25.950.03
+0.11%
Calamos S&P 500 Structured Alt Protection ETF - March
INDY43.750.03
+0.07%
iShares India 50 ETF
XMAY36.15N/A
N/A
FT Vest US Eq Enh & Mod Buf ETF-May

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with CELC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-3.71%
CELC - GLSI
37%
Loosely correlated
-1.44%
RZLT - GLSI
34%
Loosely correlated
-3.28%
MBIO - GLSI
32%
Poorly correlated
-3.36%
SPRY - GLSI
32%
Poorly correlated
-8.88%
IPSC - GLSI
32%
Poorly correlated
-7.76%
More